Synthes Executives Plead Guilty, Company Faces Court Date

Devices & Diagnostics Letter
Three of four Synthes officials charged in connection with off-label promotion and illegal clinical trials of a bone void filler pleaded guilty last week to a misdemeanor of introducing misbranded Norian XR into interstate commerce.

To View This Article:


Buy This Article Now

Add this article to your cart for $10.00